The osteopathic treatment of patients with gastroesophageal reflux disease (GERD). A randomized controlled trial

Not Applicable

• Conditions: K21; Gastro-oesophageal reflux disease

• Registration Number: DRKS00006824
• Lead Sponsor: Praxis für Osteopathie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09-30
• Study Completion: 2016-09-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1.) Patients who suffer from gastroesophageal reflux symptoms, at least for a half year and at least 1-2 / week
2.) Endoscopy less than 1 year without pathological findings. Only patients with grade I according to Savary / Miller will be included.
3.) Reflux diagnosed by a physician

Exclusion Criteria

Neoplasms, Barrett esophagus, reflux grade II, III, IV according to Savary/Miller, reflux during pregnancy, heart disease, esophageal varices, diabetic neuropathies, alcoholic neuropathy, surgery in the gastrointestinal tract in the last 6 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastrointestinal symptoms will be measured with the Reflux disease Questionnaire (RDQ) at the begin of the trial (baseline) and at the end of treatments (eight weeks after study begin)

Secondary Outcome Measures

Name	Time	Method
Quality of life, measured with the QORAD-questionnaire (Quality of Life in Reflux and Dyspepsia) at begin and end, use of medication (medication diary during the whole study), osteopathic dysfunctions (as quantitative listing) <br><br><br>